{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T14:58:15Z","timestamp":1774969095919,"version":"3.50.1"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T00:00:00Z","timestamp":1762905600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T00:00:00Z","timestamp":1762905600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015822","name":"Fondazione Roma","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100015822","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s00417-025-07024-z","type":"journal-article","created":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T10:02:30Z","timestamp":1762941750000},"page":"445-454","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Early prediction of macular neovascularization phenotypes and prognostic evolution"],"prefix":"10.1007","volume":"264","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6214-6270","authenticated-orcid":false,"given":"Serena","family":"Fragiotta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2223-7311","authenticated-orcid":false,"given":"Mariacristina","family":"Parravano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9916-8895","authenticated-orcid":false,"given":"Eliana","family":"Costanzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3242-8020","authenticated-orcid":false,"given":"Daniele","family":"De Geronimo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6530-1563","authenticated-orcid":false,"given":"Monica","family":"Varano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2815-5031","authenticated-orcid":false,"given":"Enrico","family":"Borrelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4828-7170","authenticated-orcid":false,"given":"Costanza","family":"Barresi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2891-2012","authenticated-orcid":false,"given":"Riccardo","family":"Sacconi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3292-9581","authenticated-orcid":false,"given":"Giuseppe","family":"Querques","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,12]]},"reference":[{"key":"7024_CR1","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1016\/j.ophtha.2012.10.036","volume":"120","author":"FL Ferris 3rd","year":"2013","unstructured":"Ferris FL 3rd, Wilkinson CP, Bird A, Chakravarthy U, Chew E, Csaky K, Sadda SR, Beckman Initiative for Macular Research Classification C (2013) Clinical classification of age-related macular degeneration. Ophthalmology 120:844\u2013851. https:\/\/doi.org\/10.1016\/j.ophtha.2012.10.036","journal-title":"Ophthalmology"},{"key":"7024_CR2","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1016\/j.ophtha.2019.11.004","volume":"127","author":"RF Spaide","year":"2020","unstructured":"Spaide RF, Jaffe GJ, Sarraf D, Freund KB, Sadda SR, Staurenghi G, Waheed NK, Chakravarthy U, Rosenfeld PJ, Holz FG, Souied EH, Cohen SY, Querques G, Ohno-Matsui K, Boyer D, Gaudric A, Blodi B, Baumal CR, Li X, Coscas GJ, Brucker A, Singerman L, Luthert P, Schmitz-Valckenberg S, Schmidt-Erfurth U, Grossniklaus HE, Wilson DJ, Guymer R, Yannuzzi LA, Chew EY, Csaky K, Mones JM, Pauleikhoff D, Tadayoni R, Fujimoto J (2020) Consensus nomenclature for reporting neovascular Age-Related macular degeneration data: consensus on neovascular Age-Related macular degeneration nomenclature study group. Ophthalmology 127:616\u2013636. https:\/\/doi.org\/10.1016\/j.ophtha.2019.11.004","journal-title":"Ophthalmology"},{"key":"7024_CR3","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1097\/IAE.0b013e3181e7976b","volume":"30","author":"KB Freund","year":"2010","unstructured":"Freund KB, Zweifel SA, Engelbert M (2010) Do we need a new classification for choroidal neovascularization in age-related macular degeneration? Retina 30:1333\u20131349. https:\/\/doi.org\/10.1097\/IAE.0b013e3181e7976b","journal-title":"Retina"},{"key":"7024_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2022.101113","author":"R Sacconi","year":"2022","unstructured":"Sacconi R, Fragiotta S, Sarraf D, Sadda SR, Freund KB, Parravano M, Corradetti G, Cabral D, Capuano V, Miere A, Costanzo E, Bandello F, Souied E, Querques G (2022) Towards a better Understanding of non-exudative choroidal and macular neovascularization. Prog Retin Eye Res: 101113. https:\/\/doi.org\/10.1016\/j.preteyeres.2022.101113","journal-title":"Prog Retin Eye Res: 101113"},{"issue":"6","key":"7024_CR5","doi-asserted-by":"publisher","DOI":"10.1177\/1120672120986370","volume":"31","author":"G Querques","year":"2021","unstructured":"Querques G, Sacconi R, Capuano V, Carnevali A, Colantuono D, Battista M, Borrelli E, Miere A, Parravano M, Costanzo E, Querques L, Souied EH, Bandello F (2021) Treatment-naive quiescent macular neovascularization secondary to AMD: the 2019 young investigator lecture of macula society. Eur J Ophthalmol 1120672120986370. https:\/\/doi.org\/10.1177\/1120672120986370","journal-title":"Eur J Ophthalmol"},{"key":"7024_CR6","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.ophtha.2016.10.036","volume":"124","author":"R Parikh","year":"2017","unstructured":"Parikh R, Ross JS, Sangaralingham LR, Adelman RA, Shah ND, Barkmeier AJ (2017) Trends of anti-vascular endothelial growth factor use in ophthalmology among privately insured and medicare advantage patients. Ophthalmology 124:352\u2013358. https:\/\/doi.org\/10.1016\/j.ophtha.2016.10.036","journal-title":"Ophthalmology"},{"key":"7024_CR7","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1136\/bjophthalmol-2018-312691","volume":"103","author":"A Low","year":"2019","unstructured":"Low A, Faridi A, Bhavsar KV, Cockerham GC, Freeman M, Fu R, Paynter R, Kondo K, Kansagara D (2019) Comparative effectiveness and harms of intravitreal antivascular endothelial growth factor agents for three retinal conditions: a systematic review and meta-analysis. Br J Ophthalmol 103:442\u2013451. https:\/\/doi.org\/10.1136\/bjophthalmol-2018-312691","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"7024_CR8","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-023-03937-7","volume":"21","author":"LM Khachigian","year":"2023","unstructured":"Khachigian LM, Liew G, Teo KYC, Wong TY, Mitchell P (2023) Emerging therapeutic strategies for unmet need in neovascular age-related macular degeneration. J Transl Med 21(1):133. https:\/\/doi.org\/10.1186\/s12967-023-03937-7","journal-title":"J Transl Med"},{"key":"7024_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25084433","author":"S Fragiotta","year":"2024","unstructured":"Fragiotta S, Bassis L, Abdolrahimzadeh B, Marino A, Sepe M, Abdolrahimzadeh S (2024) Exploring current molecular targets in the treatment of neovascular age-related macular degeneration toward the perspective of long-term agents. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms25084433","journal-title":"Int J Mol Sci"},{"key":"7024_CR10","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1001\/jamaophthalmol.2019.0868","volume":"137","author":"JA Hallak","year":"2019","unstructured":"Hallak JA, de Sisternes L, Osborne A, Yaspan B, Rubin DL, Leng T (2019) Imaging, genetic, and demographic factors associated with conversion to neovascular age-related macular degeneration: secondary analysis of a randomized clinical trial. JAMA Ophthalmol 137:738\u2013744. https:\/\/doi.org\/10.1001\/jamaophthalmol.2019.0868","journal-title":"JAMA Ophthalmol"},{"key":"7024_CR11","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1097\/ICU.0b013e32835fefee","volume":"24","author":"AW Scott","year":"2013","unstructured":"Scott AW, Bressler SB (2013) Long-term follow-up of vascular endothelial growth factor inhibitor therapy for neovascular age-related macular degeneration. Curr Opin Ophthalmol 24:190\u2013196. https:\/\/doi.org\/10.1097\/ICU.0b013e32835fefee","journal-title":"Curr Opin Ophthalmol"},{"key":"7024_CR12","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.oret.2023.10.006","volume":"8","author":"L Csincsik","year":"2024","unstructured":"Csincsik L, Muldrew KA, Bettiol A, Wright DM, Rosenfeld PJ, Waheed NK, Empeslidis T, De Cock E, Yamaguchi TCN, Hogg RE, Peto T, Chakravarthy U (2024) The double layer sign is highly predictive of progression to exudation in age-related macular degeneration. Ophthalmol Retina 8:234\u2013245. https:\/\/doi.org\/10.1016\/j.oret.2023.10.006","journal-title":"Ophthalmol Retina"},{"key":"7024_CR13","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1097\/IAE.0000000000001540","volume":"38","author":"S Fragiotta","year":"2018","unstructured":"Fragiotta S, Rossi T, Cutini A, Grenga PL, Vingolo EM (2018) Predictive factors for development of neovascular age-related macular degeneration: a spectral-domain optical coherence tomography study. Retina 38:245\u2013252. https:\/\/doi.org\/10.1097\/IAE.0000000000001540","journal-title":"Retina"},{"key":"7024_CR14","doi-asserted-by":"publisher","first-page":"3431","DOI":"10.1167\/iovs.18-24143","volume":"59","author":"M Nassisi","year":"2018","unstructured":"Nassisi M, Fan W, Shi Y, Lei J, Borrelli E, Ip M, Sadda SR (2018) Quantity of intraretinal hyperreflective foci in patients with intermediate age-related macular degeneration correlates with 1-year progression. Invest Ophthalmol Vis Sci 59:3431\u20133439. https:\/\/doi.org\/10.1167\/iovs.18-24143","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"7024_CR15","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1016\/j.ophtha.2019.05.016","volume":"126","author":"M Nassisi","year":"2019","unstructured":"Nassisi M, Lei J, Abdelfattah NS, Karamat A, Balasubramanian S, Fan W, Uji A, Marion KM, Baker K, Huang X, Morgenthien E, Sadda SR (2019) OCT risk factors for development of late Age-Related macular degeneration in the fellow eyes of patients enrolled in the HARBOR study. Ophthalmology 126:1667\u20131674. https:\/\/doi.org\/10.1016\/j.ophtha.2019.05.016","journal-title":"Ophthalmology"},{"key":"7024_CR16","doi-asserted-by":"publisher","first-page":"5743","DOI":"10.1038\/s41598-021-85110-y","volume":"11","author":"WD Vogl","year":"2021","unstructured":"Vogl WD, Bogunovic H, Waldstein SM, Riedl S, Schmidt-Erfurth U (2021) Spatio-temporal alterations in retinal and choroidal layers in the progression of age-related macular degeneration (AMD) in optical coherence tomography. Sci Rep 11:5743. https:\/\/doi.org\/10.1038\/s41598-021-85110-y","journal-title":"Sci Rep"},{"key":"7024_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10102370","author":"DR Muth","year":"2022","unstructured":"Muth DR, Toro MD, Bajka A, Jonak K, Rieder R, Kohler MM, Gunzinger JM, Souied EH, Engelbert M, Freund KB, Zweifel SA (2022) Correlation between macular neovascularization (MNV) type and druse type in neovascular age-related macular degeneration (AMD) based on the CONAN classification. Biomedicines. https:\/\/doi.org\/10.3390\/biomedicines10102370","journal-title":"Biomedicines"},{"key":"7024_CR18","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.1038\/s41433-022-02231-y","volume":"37","author":"T Mathis","year":"2023","unstructured":"Mathis T, Holz FG, Sivaprasad S, Yoon YH, Eter N, Chen LJ, Koh A, Cunha de Souza E, Staurenghi G (2023) Characterisation of macular neovascularisation subtypes in age-related macular degeneration to optimise treatment outcomes. Eye (Lond) 37:1758\u20131765. https:\/\/doi.org\/10.1038\/s41433-022-02231-y","journal-title":"Eye (Lond)"},{"key":"7024_CR19","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.ophtha.2017.09.028","volume":"125","author":"SR Sadda","year":"2018","unstructured":"Sadda SR, Guymer R, Holz FG, Schmitz-Valckenberg S, Curcio CA, Bird AC, Blodi BA, Bottoni F, Chakravarthy U, Chew EY, Csaky K, Danis RP, Fleckenstein M, Freund KB, Grunwald J, Hoyng CB, Jaffe GJ, Liakopoulos S, Mones JM, Pauleikhoff D, Rosenfeld PJ, Sarraf D, Spaide RF, Tadayoni R, Tufail A, Wolf S, Staurenghi G (2018) Consensus definition for atrophy associated with age-related macular degeneration on OCT: classification of atrophy report 3. Ophthalmology 125:537\u2013548. https:\/\/doi.org\/10.1016\/j.ophtha.2017.09.028","journal-title":"Ophthalmology"},{"key":"7024_CR20","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1016\/j.ophtha.2020.03.031","volume":"127","author":"SR Sadda","year":"2020","unstructured":"Sadda SR, Abdelfattah NS, Lei J, Shi Y, Marion KM, Morgenthien E, Gune S, Balasubramanian S (2020) Spectral-domain OCT analysis of risk factors for macular atrophy development in the HARBOR study for neovascular age-related macular degeneration. Ophthalmology 127:1360\u20131370. https:\/\/doi.org\/10.1016\/j.ophtha.2020.03.031","journal-title":"Ophthalmology"},{"key":"7024_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10384-022-00943-y","volume":"67","author":"Y Sakurada","year":"2023","unstructured":"Sakurada Y, Tanaka K, Fragiotta S (2023) Differentiating drusen and drusenoid deposits subtypes on multimodal imaging and risk of advanced age-related macular degeneration. Jpn J Ophthalmol 67:1\u201313. https:\/\/doi.org\/10.1007\/s10384-022-00943-y","journal-title":"Jpn J Ophthalmol"},{"key":"7024_CR22","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/j.survophthal.2018.05.005","volume":"63","author":"RF Spaide","year":"2018","unstructured":"Spaide RF, Ooto S, Curcio CA (2018) Subretinal drusenoid deposits AKA pseudodrusen. Surv Ophthalmol 63:782\u2013815. https:\/\/doi.org\/10.1016\/j.survophthal.2018.05.005","journal-title":"Surv Ophthalmol"},{"key":"7024_CR23","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.10-6024","volume":"52","author":"W Rahman","year":"2011","unstructured":"Rahman W, Chen FK, Yeoh J, Patel P, Tufail A, Da Cruz L (2011) Repeatability of manual subfoveal choroidal thickness measurements in healthy subjects using the technique of enhanced depth imaging optical coherence tomography. Invest Ophthalmol Vis Sci 52:2267. https:\/\/doi.org\/10.1167\/iovs.10-6024","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"7024_CR24","doi-asserted-by":"publisher","unstructured":"Spaide RF, Jaffe GJ, Sarraf D, Freund KB, Sadda SR, Staurenghi G, Waheed NK, Chakravarthy U, Rosenfeld PJ, Holz FG, Souied EH, Cohen SY, Querques G, Ohno-Matsui K, Boyer D, Gaudric A, Blodi B, Baumal CR, Li X, Coscas GJ, Brucker A, Singerman L, Luthert P, Schmitz-Valckenberg S, Schmidt-Erfurth U, Grossniklaus HE, Wilson DJ, Guymer R, Yannuzzi LA, Chew EY, Csaky K, Mones JM, Pauleikhoff D, Tadayoni R, Fujimoto J (2019) Consensus Nomenclature for Reporting Neovascular Age-Related Macular Degeneration Data: Consensus on Neovascular Age-Related Macular Degeneration Nomenclature Study Group. Ophthalmology https:\/\/doi.org\/10.1016\/j.ophtha.2019.11.004","DOI":"10.1016\/j.ophtha.2019.11.004"},{"key":"7024_CR25","doi-asserted-by":"publisher","first-page":"3836","DOI":"10.1167\/iovs.18-23960","volume":"59","author":"A Invernizzi","year":"2018","unstructured":"Invernizzi A, Benatti E, Cozzi M, Erba S, Vaishnavi S, Vupparaboina KK, Staurenghi G, Chhablani J, Gillies M, Viola F (2018) Choroidal structural changes correlate with neovascular activity in neovascular age related macular degeneration. Invest Ophthalmol Vis Sci 59:3836\u20133841. https:\/\/doi.org\/10.1167\/iovs.18-23960","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"7024_CR26","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1167\/iovs.64.13.16","volume":"64","author":"M Shen","year":"2023","unstructured":"Shen M, Zhou H, Lu J, Li J, Jiang X, Trivizki O, Laiginhas R, Liu J, Zhang Q, de Sisternes L, Feuer WJ, O\u2019Brien R, Gregori G, Wang RK, Rosenfeld PJ (2023) Choroidal changes after Anti-VEGF therapy in AMD eyes with different types of macular neovascularization using Swept-Source OCT angiography. Invest Ophthalmol Vis Sci 64:16. https:\/\/doi.org\/10.1167\/iovs.64.13.16","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"10","key":"7024_CR27","doi-asserted-by":"publisher","first-page":"3836","DOI":"10.1167\/iovs.18-23960","volume":"59","author":"A Invernizzi","year":"2018","unstructured":"Invernizzi A, Benatti E, Cozzi M, Erba S, Vaishnavi S, Vupparaboina K, Staurenghi G, Chhablani J, Gillies M, Viola F (2018) Choroidal structural changes correlate with neovascular activity in neovascular age related macular degeneration. Invest Ophthalmol Vis Sci 59(10):3836\u20133841. https:\/\/doi.org\/10.1167\/iovs.18-23960","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"7024_CR28","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1097\/IAE.0000000000002845","volume":"41","author":"JY Park","year":"2021","unstructured":"Park JY, Kang MJ, Kim BG, Chung KH, Sim HE, Lee SW, Kim JS, Lee HS, Hwang JH (2021) Topographic changes in choroidal thickness in age-related macular degeneration during the development of active choroidal neovascularization. Retina 41:409\u2013422. https:\/\/doi.org\/10.1097\/IAE.0000000000002845","journal-title":"Retina"},{"key":"7024_CR29","doi-asserted-by":"publisher","first-page":"3199","DOI":"10.1167\/iovs.18-24106","volume":"59","author":"U Schmidt-Erfurth","year":"2018","unstructured":"Schmidt-Erfurth U, Waldstein SM, Klimscha S, Sadeghipour A, Hu X, Gerendas BS, Osborne A, Bogunovic H (2018) Prediction of individual disease conversion in early AMD using artificial intelligence. Invest Ophthalmol Vis Sci 59:3199\u20133208. https:\/\/doi.org\/10.1167\/iovs.18-24106","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"7024_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/s12886-020-01651-2","volume":"20","author":"D Ahmed","year":"2020","unstructured":"Ahmed D, Stattin M, Haas AM, Graf A, Krepler K, Ansari-Shahrezaei S (2020) Drusen characteristics of type 2 macular neovascularization in age-related macular degeneration. BMC Ophthalmol 20:381. https:\/\/doi.org\/10.1186\/s12886-020-01651-2","journal-title":"BMC Ophthalmol"},{"key":"7024_CR31","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1111\/aos.12437","volume":"92","author":"A Caramoy","year":"2014","unstructured":"Caramoy A, Ristau T, Lechanteur YT, Ersoy L, M\u00fcller S, Gelisken F, Hoyng CB, Kirchhof B, den Hollander AI, Fauser S (2014) Environmental and genetic risk factors for retinal angiomatous proliferation. Acta Ophthalmol 92:745\u2013748. https:\/\/doi.org\/10.1111\/aos.12437","journal-title":"Acta Ophthalmol"},{"key":"7024_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/s41433-024-03034-z","author":"B Haj Najeeb","year":"2024","unstructured":"Haj Najeeb B, Schmidt-Erfurth U (2024) The potential key role of choroidal non-perfusion and rod degeneration in the pathogenesis of macular neovascularization type 3. Eye (Lond). https:\/\/doi.org\/10.1038\/s41433-024-03034-z","journal-title":"Eye (Lond)"},{"key":"7024_CR33","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/j.ophtha.2015.10.034","volume":"123","author":"E Daniel","year":"2016","unstructured":"Daniel E, Shaffer J, Ying GS, Grunwald JE, Martin DF, Jaffe GJ, Maguire MG (2016) Outcomes in eyes with retinal angiomatous proliferation in the comparison of Age-Related macular degeneration treatments trials (CATT). Ophthalmology 123:609\u2013616. https:\/\/doi.org\/10.1016\/j.ophtha.2015.10.034","journal-title":"Ophthalmology"},{"key":"7024_CR34","doi-asserted-by":"publisher","first-page":"100280","DOI":"10.1016\/j.xops.2023.100280","volume":"3","author":"A Berlin","year":"2023","unstructured":"Berlin A, Cabral D, Chen L, Messinger JD, Balaratnasingam C, Mendis R, Ferrara D, Freund KB, Curcio CA (2023) Histology of type 3 macular neovascularization and microvascular anomalies in treated Age-Related macular degeneration: A case study. Ophthalmol Sci 3:100280. https:\/\/doi.org\/10.1016\/j.xops.2023.100280","journal-title":"Ophthalmol Sci"},{"key":"7024_CR35","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1097\/IAE.0000000000000086","volume":"34","author":"T Yamazaki","year":"2014","unstructured":"Yamazaki T, Koizumi H, Yamagishi T, Kinoshita S (2014) Subfoveal choroidal thickness in retinal angiomatous proliferation. Retina 34:1316\u20131322. https:\/\/doi.org\/10.1097\/IAE.0000000000000086","journal-title":"Retina"},{"key":"7024_CR36","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.ajo.2003.09.042","volume":"137","author":"HE Grossniklaus","year":"2004","unstructured":"Grossniklaus HE, Green WR (2004) Choroidal neovascularization. Am J Ophthalmol 137:496\u2013503. https:\/\/doi.org\/10.1016\/j.ajo.2003.09.042","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"7024_CR37","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s00417-003-0828-0","volume":"242","author":"RO Schlingemann","year":"2004","unstructured":"Schlingemann RO (2004) Role of growth factors and the wound healing response in age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol 242(1):91\u2013101. https:\/\/doi.org\/10.1007\/s00417-003-0828-0","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"7024_CR38","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.ajo.2023.12.011","volume":"261","author":"KYC Teo","year":"2024","unstructured":"Teo KYC, Zhao J, Ibrahim FI, Fenner B, Chakravarthy U, Cheung CMG (2024) Features associated with vision in eyes with subfoveal fibrosis from neovascular age-related macular degeneration. Am J Ophthalmol 261:121\u2013131. https:\/\/doi.org\/10.1016\/j.ajo.2023.12.011","journal-title":"Am J Ophthalmol"},{"key":"7024_CR39","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.ajo.2023.03.033","volume":"252","author":"F Romano","year":"2023","unstructured":"Romano F, Cozzi E, Airaldi M, Nassisi M, Viola F, Aretti A, Milella P, Giuffrida FP, Teo KCY, Cheung CMG, Staurenghi G, Invernizzi A (2023) Ten-year incidence of fibrosis and risk factors for its development in neovascular age-related macular degeneration. Am J Ophthalmol 252:170\u2013181. https:\/\/doi.org\/10.1016\/j.ajo.2023.03.033","journal-title":"Am J Ophthalmol"},{"key":"7024_CR40","doi-asserted-by":"publisher","DOI":"10.1097\/iae.0000000000000460","volume":"35","author":"M Marsiglia","year":"2015","unstructured":"Marsiglia M, Boddu S, Chen C, Jung J, Mrejen S, Gallego-Pinazo R, Freund K (2015) Correlation between neovascular lesion type and clinical characteristics of nonneovascular fellow eyes in patients with unilateral, neovascular age-related macular degeneration. Retina 35:966. https:\/\/doi.org\/10.1097\/iae.0000000000000460","journal-title":"Retina"},{"key":"7024_CR41","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1007\/s00417-014-2601-y","volume":"252","author":"S Yoneyama","year":"2014","unstructured":"Yoneyama S, Sakurada Y, Mabuchi F, Imasawa M, Sugiyama A, Kubota T, Iijima H (2014) Genetic and clinical factors associated with reticular pseudodrusen in exudative age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol 252:1435\u20131441. https:\/\/doi.org\/10.1007\/s00417-014-2601-y","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"3","key":"7024_CR42","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1167\/iovs.11-8907","volume":"53","author":"G Querques","year":"2012","unstructured":"Querques G, Querques L, Forte R, Massamba N, Coscas F, Souied E (2012) Choroidal changes associated with reticular pseudodrusen. Invest Ophthalmol Vis Sci 53(3):1258\u20131263. https:\/\/doi.org\/10.1167\/iovs.11-8907","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"7024_CR43","doi-asserted-by":"publisher","first-page":"2604","DOI":"10.1097\/iae.0000000000000633","volume":"35","author":"JH Kim","year":"2015","unstructured":"Kim JH, Chang Y, Kim JW, Lee T, Kim C (2015) Prevalence of subtypes of reticular pseudodrusen in newly diagnosed exudative age-related macular degeneration and polypoidal choroidal vasculopathy in Korean patients. Retina 35:2604. https:\/\/doi.org\/10.1097\/iae.0000000000000633","journal-title":"Retina"},{"key":"7024_CR44","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1097\/iae.0000000000003945","volume":"44","author":"E Bousquet","year":"2024","unstructured":"Bousquet E, Santina A, Corradetti G, Sacconi R, Ramtohul P, Bijon J, Somisetty S, Voichanski S, Querques G, Sadda S, Freund KB, Sarraf D (2024) From drusen to type 3 macular neovascularization. Retina 44:189\u2013196. https:\/\/doi.org\/10.1097\/iae.0000000000003945","journal-title":"Retina"},{"key":"7024_CR45","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1136\/bjophthalmol-2021-318820","volume":"106","author":"R Sacconi","year":"2022","unstructured":"Sacconi R, Brambati M, Miere A, Costanzo E, Capuano V, Borrelli E, Battista M, Parravano M, Souied EH, Bandello F, Querques G (2022) Characterisation of macular neovascularisation in geographic atrophy. Br J Ophthalmol 106:1282\u20131287. https:\/\/doi.org\/10.1136\/bjophthalmol-2021-318820","journal-title":"Br J Ophthalmol"},{"key":"7024_CR46","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1016\/j.oret.2023.01.019","volume":"7","author":"R Sacconi","year":"2023","unstructured":"Sacconi R, Sarraf D, Sadda SR, Freund KB, Servillo A, Fogel Levin MM, Costanzo E, Corradetti G, Cabral D, Zur D, Trivizki O, Parravano M, Bandello F, Loewenstein A, Querques G (2023) Nascent geographic atrophy as a predictor of type 3 macular neovascularization development. Ophthalmol Retina 7:586\u2013592. https:\/\/doi.org\/10.1016\/j.oret.2023.01.019","journal-title":"Ophthalmol Retina"},{"issue":"Suppl 1","key":"7024_CR47","doi-asserted-by":"publisher","first-page":"S40","DOI":"10.1097\/IAE.0000000000001268","volume":"36","author":"D Su","year":"2016","unstructured":"Su D, Lin S, Phasukkijwatana N, Chen X, Tan A, Freund KB, Sarraf D (2016) An updated staging system of type 3 neovascularization using spectral domain optical coherence tomography. Retina 36(Suppl 1):S40\u2013S49. https:\/\/doi.org\/10.1097\/IAE.0000000000001268","journal-title":"Retina"},{"key":"7024_CR48","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/j.ajo.2008.12.008","volume":"147","author":"R Margolis","year":"2009","unstructured":"Margolis R, Spaide RF (2009) A pilot study of enhanced depth imaging optical coherence tomography of the choroid in normal eyes. Am J Ophthalmol 147:811\u2013815. https:\/\/doi.org\/10.1016\/j.ajo.2008.12.008","journal-title":"Am J Ophthalmol"},{"key":"7024_CR49","doi-asserted-by":"publisher","first-page":"101017","DOI":"10.1016\/j.preteyeres.2021.101017","volume":"88","author":"Z Wu","year":"2022","unstructured":"Wu Z, Fletcher EL, Kumar H, Greferath U, Guymer RH (2022) Reticular pseudodrusen: A critical phenotype in age-related macular degeneration. Prog Retin Eye Res 88:101017. https:\/\/doi.org\/10.1016\/j.preteyeres.2021.101017","journal-title":"Prog Retin Eye Res"},{"key":"7024_CR50","doi-asserted-by":"publisher","first-page":"2437","DOI":"10.1007\/s00417-022-05586-w","volume":"260","author":"KB Freund","year":"2022","unstructured":"Freund KB, Staurenghi G, Jung JJ, Zweifel SA, Cozzi M, Hill L, Blotner S, Tsuboi M, Gune S (2022) Macular neovascularization lesion type and vision outcomes in neovascular age-related macular degeneration: post hoc analysis of HARBOR. Graefes Arch Clin Exp Ophthalmol 260:2437\u20132447. https:\/\/doi.org\/10.1007\/s00417-022-05586-w","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"7024_CR51","first-page":"2857","volume":"35","author":"RS Ramrattan","year":"1994","unstructured":"Ramrattan RS, van der Schaft TL, Mooy CM, de Bruijn WC, Mulder PG, de Jong PT (1994) Morphometric analysis of bruch\u2019s membrane, the choriocapillaris, and the choroid in aging. Invest Ophthalmol Vis Sci 35:2857\u20132864","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"7024_CR52","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1167\/iovs.14-14933","volume":"56","author":"M Lindner","year":"2015","unstructured":"Lindner M, Bezatis A, Czauderna J, Becker E, Brinkmann CK, Schmitz-Valckenberg S, Fimmers R, Holz FG, Fleckenstein M (2015) Choroidal thickness in geographic atrophy secondary to age-related macular degeneration. Invest Ophthalmol Vis Sci 56:875\u2013882. https:\/\/doi.org\/10.1167\/iovs.14-14933","journal-title":"Invest Ophthalmol Vis Sci"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-025-07024-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00417-025-07024-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-025-07024-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T07:43:28Z","timestamp":1771573408000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00417-025-07024-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,12]]},"references-count":52,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["7024"],"URL":"https:\/\/doi.org\/10.1007\/s00417-025-07024-z","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,12]]},"assertion":[{"value":"16 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the IRCCS-Bietti Foundation, Rome (IT) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"S. Fragiotta has received a speaker honorarium from Bayer. M. Parravano has received personal fees as speaker and consultant from Abbvie, Novartis, Bayer, Zeiss, Omikron, Alfaintes, Sifi. M. Varano has received a speaker and consultant honorarium from Abbvie, Novartis, Bayer, Sifi. E. Borrelli, reports personal feed from Abbvie, Bayer, Hofmann La Roche, Zeiss; R. Sacconi has received a speaker and consultant honorarium from Novartis, Bayer, Zeiss. G. Querques has received a speaker and consultant honorarium from Alimera Sciences, Inc; Allegro, Abbvie, Apellis, Baush & Lomb, Bayer Healthcare Pharmaceuticals, Boehringer Ingelheim, CenterVue, Heidelberg Engineering, Lumithera, Nevacar, Novartis Pharmaceuticals Corporation, Roche, SIFI, Sooft\/Fidia, Topcon, Thea, Zeiss. All the personal fees reported are outside the submitted work.The remaining authors have no proprietary\/financial interest or non-financial interest in the subject matter or materials discussed in this manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}